Race, Ethnicity, and Diffuse Parenchymal Lung Disease



Status:Completed
Conditions:Lung Cancer, Pulmonary
Therapuetic Areas:Oncology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:Any
Updated:10/21/2012
Start Date:February 2007
End Date:October 2012
Contact:Nisha A Philip, MBBS.
Email:np2173@columbia.edu
Phone:(212) 305-7720

Use our guide to learn which trials are right for you!

Determinants of Outcome in Diffuse Parenchymal Lung Disease


The purpose of this study is to identify factors that contribute to higher mortality rates
among blacks and Hispanics with diffuse parenchymal lung disease.


It is well known that both socioeconomic and biological factors may contribute to race- and
ethnicity-based health disparities. Black and Hispanic Americans have worse access to
healthcare services and tend to receive care from physicians who cannot themselves access
the same services for their patients that physicians who care for white patients can. These
factors may play important roles in the development and maintenance of health disparities.
In addition, biological differences may contribute to disparities. We propose to identify
factors that explain survival disparities in a group of lung diseases called diffuse
parenchymal lung diseases (DPLDs), including a severe form of DPLD called idiopathic
pulmonary fibrosis (IPF). We will follow patients with DPLD at our center and measure both
social and biological factors to try to identify the factors that lead to survival
disparities between races. Results of this study will be used to design clinical trials
aimed at reducing these disparities.

Inclusion Criteria:

- Diagnosis of IPF or other DPLD according to ATS criteria

- Signed informed consent

Exclusion Criteria:

- None
We found this trial at
1
site
630 W 168th St
New York, New York
212-305-2862
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
?
mi
from
New York, NY
Click here to add this to my saved trials